Amanote Research

Amanote Research

    RegisterSign In

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (Literature Review)

Oncogematologiya - Russian Federation
doi 10.17650/1818-8346-2018-13-2-32-38
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyHematology
Date

July 12, 2018

Authors
T. E. Byalik
Publisher

Publishing House ABV Press


Related search

Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature

Oncologist
Cancer ResearchMedicineOncology
2019English

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia

ISRN Oncology
2014English

Second Lung Malignancy and Richter Syndrome in Chronic Lymphocytic Leukemia: Case Report and Literature Review

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Outcomes With Bruton Tyrosine Kinase Inhibition in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Progression on Venetoclax

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy